It was reported today that multinational pharmaceutical company Novo Nordisk announced that the China National Medical Products Administration had approved the company’s application to market Novo Nordisk’s Wegovy (for long-term weight management) in China. Novo Nordisk stated that the price of the product will be announced upon its commercial launch. The company has initiated the relevant processes for drug supply according to plan.